全文获取类型
收费全文 | 114103篇 |
免费 | 12419篇 |
国内免费 | 8176篇 |
专业分类
耳鼻咽喉 | 1065篇 |
儿科学 | 1199篇 |
妇产科学 | 999篇 |
基础医学 | 11721篇 |
口腔科学 | 2421篇 |
临床医学 | 14817篇 |
内科学 | 14115篇 |
皮肤病学 | 1168篇 |
神经病学 | 5079篇 |
特种医学 | 4162篇 |
外国民族医学 | 49篇 |
外科学 | 11778篇 |
综合类 | 24271篇 |
现状与发展 | 32篇 |
一般理论 | 8篇 |
预防医学 | 9303篇 |
眼科学 | 2724篇 |
药学 | 12864篇 |
163篇 | |
中国医学 | 8592篇 |
肿瘤学 | 8168篇 |
出版年
2024年 | 527篇 |
2023年 | 1974篇 |
2022年 | 5137篇 |
2021年 | 6352篇 |
2020年 | 5225篇 |
2019年 | 3857篇 |
2018年 | 3941篇 |
2017年 | 4087篇 |
2016年 | 3626篇 |
2015年 | 5569篇 |
2014年 | 6792篇 |
2013年 | 6674篇 |
2012年 | 9963篇 |
2011年 | 10149篇 |
2010年 | 7388篇 |
2009年 | 6126篇 |
2008年 | 6843篇 |
2007年 | 6501篇 |
2006年 | 5938篇 |
2005年 | 5157篇 |
2004年 | 3752篇 |
2003年 | 3673篇 |
2002年 | 3058篇 |
2001年 | 2464篇 |
2000年 | 2020篇 |
1999年 | 1710篇 |
1998年 | 932篇 |
1997年 | 970篇 |
1996年 | 725篇 |
1995年 | 655篇 |
1994年 | 508篇 |
1993年 | 339篇 |
1992年 | 410篇 |
1991年 | 333篇 |
1990年 | 291篇 |
1989年 | 226篇 |
1988年 | 180篇 |
1987年 | 192篇 |
1986年 | 135篇 |
1985年 | 107篇 |
1984年 | 57篇 |
1983年 | 39篇 |
1982年 | 21篇 |
1981年 | 25篇 |
1980年 | 11篇 |
1979年 | 18篇 |
1978年 | 4篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1926年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献
4.
Lei Yang You-Ling Shi Yan Ma Wei-Wei Ren Guang-Ming Pang Jiao Liu 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2022,130(1):43-52
Krüppel-like factor 16 (KLF16), a member of the Krüppel-like factor (KLF) family, has been extensively investigated in multiple cancer types. However, the role of KLF16 in oral squamous cell carcinoma (OSCC) remains unknown. Thus, we conducted this study to investigate its related mechanism. KLF16 expression in OSCC cell lines was quantified by western blotting. Then, OECM1 and OC3 cells were divided into Blank, siCtrl, siKLF16#1 and siKLF16#2 groups. Subsequently, cell proliferation was detected using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assays, cell migration and invasion were detected with wound healing and Transwell assays, and cell cycle distribution and cell apoptosis were detected via flow cytometry. KLF16, p21, CDK4, Cyclin D1 and p-Rb expression was detected by western blotting. Finally, xenograft models were established in nude mice to observe the in vivo effects of KLF16 on OSCC. KLF16 protein expression was upregulated in OSCC cells. Compared to the cells in the Blank group, the OECM1 and OC3 cells in the siKLF16#1 group and siKLF16#2 group exhibited a sharp decrease in proliferation but a remarkable increase in apoptosis. Moreover, the proportion of cells in the G0/G1 phase notably increased and that in the S phase decreased, with evident decreases in cell invasion and migration. Moreover, KLF16, cyclin-dependent kinase 4 (CDK4), Cyclin D1 and p-Rb protein expression was upregulated, but p21 expression was downregulated. The mice in the siKLF16#1 and siKLF16#2 xenograft model groups exhibited slower tumour growth and smaller tumours with evident downregulation of Ki67 expression compared to the mice in the Blank group. KLF16 expression was upregulated in OSCC cells, and interfering with KLF16 led to cell cycle arrest, inhibited OSCC cell growth and promoted cell apoptosis. 相似文献
5.
6.
7.
8.
9.
10.
目的:观察非霍奇金淋巴瘤(non-Hodgkin's lymphoma,NHL)患者自体造血干细胞移植(autologous hematopoietic stem cell transplantation,ASCT)术后应用重组人α-2b干扰素(α-2b IFN)进行早期干预治疗的临床疗效。方法:选取18例行ASCT的NHL患者为研究对象,移植前疾病评估均未达到完全缓解(complete remission,CR),试验组血象恢复后给予IFN 3 000 000 U次/隔日干预治疗,3个月后停用;对照组未行干扰素干预治疗,分析总体疗效及两组对比的生存情况。结果:随访中位时间为34(10~50)个月,患者中位生存时间为37(31~45)个月,3年总体无进展生存(progressive free survival,PFS)、总生存(overall survivial,OS)分别为54.7%、66.8%。ASCT后试验组1年内无疾病复发,2年内复发率为12.5%;对照组1年内复发率为20%,2年内复发率为30%。结论:NHL患者在ASCT后给予重组人α-2b IFN早期干预治疗,患者耐受性好,可能降低移植后早期复发率。 相似文献